Results 231 to 240 of about 204,978 (241)

A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as monotherapy for patients with neuromyelitis optica spectrum disorder (NMOSD)

2018
openaire   +1 more source

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Journal of Experimental Medicine, 1989
Shin Yonehara
exaly  

Modeling approach to investigate the effect of neonatal Fc receptor binding affinity and anti-therapeutic antibody on the pharmacokinetic of humanized monoclonal anti-tumor necrosis factor-α IgG antibody in cynomolgus monkey

European Journal of Pharmaceutical Sciences, 2014
Chee M Ng, Suhasini Iyer, Paul J Fielder
exaly  

Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis

Peptides, 2019
Giuseppe Tringali, Pierluigi Navarra
exaly  

Inhibiting monoclonal antibody GDF-15 improves cancer cachexia symptoms

Ca-A Cancer Journal for Clinicians
Mike Fillon
exaly  

Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody

Neoplasia, 2007
Ira Mellman, Andrew M Scott, Derek Toomre   +2 more
exaly  

Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes

European Journal of Immunology, 1993
Ernest Choy, Gabriel S Panayi, G H Kingsley   +2 more
exaly  

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

Cancer and Metastasis Reviews, 1998
Patricia Rockwell, Daniel J Hicklin, Larry Witte   +2 more
exaly  

An anti-acetylcholine receptor monoclonal antibody cross-reacts with phosvitin

FEBS Letters, 1983
Sara Fuchs, Adrienne S Gordon, A S Gordon   +2 more
exaly  

Anti-IL-23 receptor monoclonal antibody prevents CD4 T cell-mediated colitis in association with decreased systemic Th1 and Th17 responses

European Journal of Pharmacology, 2018
exaly